TMDX
Chart
Ratings & dials
1m · 5m · 15m · 1h · 4h · 1DAnalyst & Morningstar ratings
Consensus · Targets · MorningstarThird-party ratings, not SURVYR.'s views.
Key stats & company
What they do
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.
Valuation and fundamentals
Valuation & fundamentals
For information only · Important disclosures
Grades vs sector
Momentum7th percentile in sectorF
Percentile within its GICS sector across the S&P 1500.
Growth80th percentile in sectorA-
Percentile within its GICS sector across the S&P 1500.
Value18th percentile in sectorD
Percentile within its GICS sector across the S&P 1500.
Profitability86th percentile in sectorA-
Percentile within its GICS sector across the S&P 1500.
RevisionsNot enough data yet–
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Systematic Models
Not held by any of our 7 live models right now.
Earnings & events
TMDX earningsNext report in 8 daysIn line = within 1% of the estimate.
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $189.9M | +20.7% |
| 2026-03-31 | $173.9M | – |
| 2025-12-31 | $160.8M | – |
| 2025-09-30 | $143.8M | – |
| 2025-06-30 | $157.4M | – |
News & catalysts
More newsRating changes
Third-party analyst actions, not SURVYR.'s views. All rating changes
Insider trades
$109.1K
–
Stats refreshed 2026-10-23 23:42:37 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
Get the market emails
Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdaysIndexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.
Check your inbox to confirm
We sent a link to . Tap it to start your emails. Nothing is sent until you confirm.
Not there in a minute? Check spam, or .
Dev mode No email provider here, so the confirm link is shown: Open confirm link
Free to use. No card, no ads, no auto-renew.
Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app
Coteau 0.9 · Oct 21, 2026